Kenya - English - Pharmacy and Poisons Board

medivet products ltd p.o box 47951-00100 nairobi kenya - ibuprofen - oral suspension - each 5ml contains ibuprofen bp 100mg - non-steroidal

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - fluconazole - powder for oral suspension - 10 milligram(s)/millilitre - triazole derivatives; fluconazole

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - fluconazole - powder for oral suspension - 40 milligram(s)/millilitre - triazole derivatives; fluconazole

United States - English - NLM (National Library of Medicine)

a-s medication solutions - flurbiprofen (unii: 5gro578klp) (flurbiprofen - unii:5gro578klp) - flurbiprofen 100 mg - flurbiprofen tablets are indicated: risk summary use of nsaids, including flurbiprofen, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including flurbiprofen, in pregnant women starting at 30 weeks of gestation (third trimester). there are no adequate and well-controlled studies of flurbiprofen in pregnant women. data from observational studies regarding potential embryo-fetal risks of nsaid use in women in the first or second trimesters of pregnancy are inconclusive. in the general u.s. population, all clinically recognized pregnancies, regardless of drug exposure, have a background rate of 2 to 4% for major malformations, and 15 to 20% for pregnancy loss. in animal reproduction studies, delayed parturition, prolonged labor, stillborn fetuses, and the presence of retained fetuses at necropsy occurred following treatment of pregnant rats treated with oral flurbiprofen throughout gestation until labor at less than 1-time t

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - flurbiprofen - oral tablet - 100mg

Ireland - English - HPRA (Health Products Regulatory Authority)

rowex ltd - ibuprofen - oral suspension - 100 mg/5ml - propionic acid derivatives

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

abbott laboratories ltd - flurbiprofen - oral tablet - 50mg

United States - English - NLM (National Library of Medicine)

caraco pharmaceutical laboratories, ltd. - flurbiprofen (unii: 5gro578klp) (flurbiprofen - unii:5gro578klp) - tablet - 50 mg - carefully consider the potential benefits and risks of flurbiprofen tablet, usp and other treatment options before deciding to use flurbiprofen tablet, usp. use the lowest effective dose for the shortest duration consistent with individual patient treatment goals (see warnings). flurbiprofen tablet, usp is indicated: - for relief of the signs and symptoms of rheumatoid arthritis. - for relief of the signs and symptoms of osteoarthritis. flurbiprofen tablets, usp are contraindicated in patients with known hypersensitivity to flurbiprofen. flurbiprofen tablet, usp should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other nonsteroidal anti-inflammatory drugs. severe, rarely fatal, anaphylactic-like reactions to nonsteroidal anti-inflammatory drugs have been reported in such patients (see warnings, anaphylactoid reactions, and precautions, preexisting asthma). flurbiprofen tablet, usp is contraindicated for the treatment of peri-operative pain

Canada - English - Health Canada

teva canada limited - flurbiprofen - tablet - 50mg - flurbiprofen 50mg - other nonsteroidal antiimflammatory agents

Canada - English - Health Canada

teva canada limited - flurbiprofen - tablet - 100mg - flurbiprofen 100mg - other nonsteroidal antiimflammatory agents